LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. Their technology is providing fast, high performance and accessible diagnostic solutions at the point of need.
This single, easy to use, portable Instrument has a simple and consistent workflow for all tests and is designed for intuitive use - simply follow the on-screen video display for high-sensitivity results in minutes.
Explore the Test Menu
SARS-CoV-2 Antigen Test- The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
CRP test - The LumiraDx CRP (C-Reactive Protein) test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify CRP levels in whole blood and plasma. Used with the LumiraDx Platform, the test delivers rapid, quantitative results in 4 minutes at the point of care.
SARS-CoV-2 & Flu A/B Test - Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results in 12 mins for patients suspected of Flu and/or COVID-19, to help decision making and guide treatment
NT-proBNP Test - The LumiraDx NT-proBNP test is a quantitative direct fingerstick NT-proBNP test. An easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP levels in whole blood and plasma, the LumiraDx NT-proBNP test delivers reliable, quantitative results in only 12 minutes at the point of need.
HbA1c Test - The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in < 7 minutes at the point of care.